ROYAL BANK OF CANADA - AVENUE THERAPEUTICS INC ownership

AVENUE THERAPEUTICS INC's ticker is ATXI and the CUSIP is 05360L205. A total of 16 filers reported holding AVENUE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AVENUE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0132
-24.6%
0.00%
Q1 2022$0175
-4.9%
0.00%
Q4 2021$0184
-12.0%
0.00%
Q3 2021$0
-100.0%
209
-83.3%
0.00%
Q2 2021$3,000
-40.0%
1,255
+65.1%
0.00%
Q1 2021$5,000
+25.0%
760
+12.4%
0.00%
Q4 2020$4,000
-82.6%
676
-68.5%
0.00%
Q3 2020$23,0000.0%2,1470.0%0.00%
Q2 2020$23,0002,147
+6034.3%
0.00%
Q1 2020$0
-100.0%
35
-58.3%
0.00%
Q4 2019$1,0000.0%84
-54.3%
0.00%
Q3 2019$1,000184
+1126.7%
0.00%
Q3 2018$0150.00%
Other shareholders
AVENUE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
EMFO, LLC 24,000$12,0000.01%
Virtu Financial LLC 58,004$28,0000.00%
TWO SIGMA SECURITIES, LLC 52,813$25,0000.00%
B. Riley Wealth Advisors, Inc. 60,330$30,0000.00%
BNP PARIBAS FINANCIAL MARKETS 8$4,0000.00%
BANK OF AMERICA CORP /DE/ 104$00.00%
WELLS FARGO & COMPANY/MN 48,062$23,0000.00%
NORTHERN TRUST CORP 13,767$7,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 84,033$40,0000.00%
View complete list of AVENUE THERAPEUTICS INC shareholders